Emerging Leaders and Pharm Exec editors mingle at the outdoor cocktail reception.
|
Pharm Exec's 2011 Emerging Pharma Leaders program convened in New York on Oct. 6 for a gathering of some of the best minds in the industry
under age 45—where we recognize 30 executives from diverse backgrounds who hope to make a difference as the industry grapples
with a future that is rift by uncertainty. With our cohost Cegedim Relationship Management, the day began with a Cegedim sponsored
roundtable discussion on "lean management" principles and ended with a dinner celebration honoring the winners at the rooftop
restaurant 220 FIFTH.
Richard Gliklich, CEO, Outcome
|
Cegedim's Angela Miccoli, left, with Leigh-Ann Durant of EMD Serono
|
EPL Jessica Monroe of Johnson & Johnson with her husband Todd
|
Cegedim's Angela Miccoli with Soma Gupta of Pfizer
|
Angela Miccoli, President of the Americas for Cegedim, along with Editor-in-Chief William Looney, presented each of the Emerging
Leaders with an award and a plaque incorporating their career profiles published in the June issue of Pharm Exec. The dinner also featured a guest speaker: Dr. Richard Gliklich, Professor at the Harvard Medical School and founder of Outcome
Inc., a leader in the development of patient registries and other tools to build an observational database on drugs. He noted
as a key trend for the future the growing size of trial data sets, whose veracity should be accompanied by "a healthy respect
for their limitations" in guiding therapy decisions that will affect millions of patients—our industry's key constituency.
– Jeff Schindler, Managing Editor
Cegedim's Angela Miccoli with David Stern of EMD Serono
|
L to R: Jeff Schindler, Managing Editor; Dave Esola, GM, Pharma/Science group; William Looney, Editor-in-Chief; and Jay Berfas,
Group Publisher, Pharm Exec
|
Cegedim's Angela Miccoli with Steven Blum of Forest Laboratories
|
PharmExec Blog
Follow Us
RSS
Bookstore
